Category:YKHC Guidelines: Difference between revisions
From Guide to YKHC Medical Practices
| (9 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
[[media:Guidelines2017.pdf|YKHC Clinical Guidelines Book] | <pre style="color: green"> | ||
If you are having difficulty finding a specific guideline, Please use Ctrl+F. "Control+F" (or "Command+F" on a Mac) is the keyboard shortcut for the Find command. If you are in a document or in a web browser, pressing the Ctrl key + the F key will bring up a search box in the top right corner of the screen. | |||
</pre> | |||
'''LOCAL GUIDELINE COLLECTIONS''' | |||
<br/>[[media:Guidelines2017.pdf|YKHC Clinical Guidelines Book]] | |||
<br/>[https://anmc.org/medical-professionals/clinical-guidelines/ ANMC Clinical Guidelines] | <br/>[https://anmc.org/medical-professionals/clinical-guidelines/ ANMC Clinical Guidelines] | ||
'''CLINICAL GUIDELINES (Arranged by system)''' | '''CLINICAL GUIDELINES (Arranged by system)''' | ||
| Line 81: | Line 86: | ||
* [[media:GBS_neonatal.pdf|Newborn Early Onset Sepsis/GBS]]; [[Newborn GBS & Infection Evaluation and Treatment|supplement]] | * [[media:GBS_neonatal.pdf|Newborn Early Onset Sepsis/GBS]]; [[Newborn GBS & Infection Evaluation and Treatment|supplement]] | ||
* [[media:Glucose_neonatal.pdf|Neonatal Glucose Screening]]; [[Neonatal Glucose Screening Evaluation and Treatment|supplement]] | * [[media:Glucose_neonatal.pdf|Neonatal Glucose Screening]]; [[Neonatal Glucose Screening Evaluation and Treatment|supplement]] | ||
* [[media:Jaundice_neonatal.pdf| | * [[media:Jaundice_neonatal.pdf|Jaundice in a Baby <4 Weeks]]; [[Jaundice – Neonatal Evaluation & Treatment|supplement]] | ||
* [[media:Neonatal resuscitation summary.pdf|Neonatal Resuscitation Summary]] | * [[media:Neonatal resuscitation summary.pdf|Neonatal Resuscitation Summary]] | ||
| Line 93: | Line 98: | ||
==Obstetrics== | ==Obstetrics== | ||
* [[media:Anemia_in_pregnancy.pdf|Anemia in Pregnancy]]; [[Anemia in Pregnancy|supplement]] | * [[media:Anemia_in_pregnancy.pdf|Anemia in Pregnancy]]; [[Anemia in Pregnancy|supplement]] | ||
* [[media:Gestational_diabetes.pdf|Diabetes,Gestational]]; [[Gestational Diabetes|supplement]] | * [[media:Gestational_diabetes.pdf|Diabetes,Gestational]]; [[Gestational Diabetes|supplement]] | ||
* [[media:Ectopic_pregnancy.pdf|Ectopic Pregnancy Treatment]]; [[Ectopic Pregnancy – Treatment|supplement]] | * [[media:Ectopic_pregnancy.pdf|Ectopic Pregnancy Treatment]]; [[Ectopic Pregnancy – Treatment|supplement]] | ||
| Line 109: | Line 113: | ||
* [[media:Oligohydramnios.pdf|Oligohydramnios]]; [[Oligohydramnios|supplement]] | * [[media:Oligohydramnios.pdf|Oligohydramnios]]; [[Oligohydramnios|supplement]] | ||
* [[media:Post_dates_pregnancy.pdf|Post Dates Pregnancy]]; [[Post Dates Pregnancy|supplement]] | * [[media:Post_dates_pregnancy.pdf|Post Dates Pregnancy]]; [[Post Dates Pregnancy|supplement]] | ||
* [[media:Prenatal_care.pdf|Prenatal Care]]; [[Prenatal Information|supplement]] | |||
* [[media:Preterm_labor.pdf|Preterm Labor (Screening, Prevention, Evaluation, and Treatment)]]; [[Preterm Labor – Screening and Prevention|supplement]] | * [[media:Preterm_labor.pdf|Preterm Labor (Screening, Prevention, Evaluation, and Treatment)]]; [[Preterm Labor – Screening and Prevention|supplement]] | ||
* [[media:PPROM.pdf|Preterm Premature Rupture of Membranes (PPROM)]]; [[Preterm Premature Rupture of Membranes|supplement]] | * [[media:PPROM.pdf|Preterm Premature Rupture of Membranes (PPROM)]]; [[Preterm Premature Rupture of Membranes|supplement]] | ||
* [[media:Anti_D_immune_globulin.pdf|Rhogam]]; [[Anti-D Immune Globulin|supplement]] | |||
* [[media:VBAC.pdf|Vaginal Birth After Cesarian (VBAC)]]; [[Vaginal Birth After Cesarian|supplement]] | * [[media:VBAC.pdf|Vaginal Birth After Cesarian (VBAC)]]; [[Vaginal Birth After Cesarian|supplement]] | ||
| Line 137: | Line 143: | ||
==COVID Guidelines== | ==COVID Guidelines== | ||
* Multisystem Inflammatory Syndrome (MIS C) | * [[media:MIS-C.pdf|Multisystem Inflammatory Syndrome (MIS C)]] | ||
* [[media:EUA_Molnupiravir.pdf|Molnupiravir, Emergency Use]] | * [[media:EUA_Molnupiravir.pdf|Molnupiravir, Emergency Use]] | ||
* [[media:EUA_Paxlovid.pdf|Paxlovid, Emergency Use]] | * [[media:EUA_Paxlovid.pdf|Paxlovid, Emergency Use]] | ||
* [[media:Return_to_sports_guideline.pdf|Sports Clearance for Pediatric Patients with History of COVID-19]] (return to play after COVID); [[Sports Clearance for Pediatric Patients with History of COVID-19|supplement]] | * [[media:Return_to_sports_guideline.pdf|Sports Clearance for Pediatric Patients with History of COVID-19]] (return to play after COVID); [[Sports Clearance for Pediatric Patients with History of COVID-19|supplement]] | ||
*Tixagevimab & Cilgavimab, Emergency Use | * [[media:EUA_tix_cil.pdf|Tixagevimab & Cilgavimab, Emergency Use]] | ||
| Line 151: | Line 157: | ||
* [[media:Surfactant_Clinical_Resource.pdf|Surfactant (Curosurf) Administration Protocol]]; [[Curosurf Administration|supplement]] | * [[media:Surfactant_Clinical_Resource.pdf|Surfactant (Curosurf) Administration Protocol]]; [[Curosurf Administration|supplement]] | ||
* [[media:Village_delivery_(peds).pdf|Village Deliveries]]; [[Pediatric Village Delivery Orientation|supplement]] | * [[media:Village_delivery_(peds).pdf|Village Deliveries]]; [[Pediatric Village Delivery Orientation|supplement]] | ||
==Outpatient Protocols/References== | ==Outpatient Protocols/References== | ||
| Line 169: | Line 171: | ||
* Endocrine Emergencies (see [[media:Endocrine pages.pdf|Endocrine Pages]]); [[Pediatric Endocrine Emergency Protocol|supplement]] | * Endocrine Emergencies (see [[media:Endocrine pages.pdf|Endocrine Pages]]); [[Pediatric Endocrine Emergency Protocol|supplement]] | ||
* Endocrine Referrals/Labs and Follow-up Recommendations (see [[media:Endocrine pages.pdf|Endocrine Pages]]) | * Endocrine Referrals/Labs and Follow-up Recommendations (see [[media:Endocrine pages.pdf|Endocrine Pages]]) | ||
* [[media:ET_CO2.pdf|ET CO2 Monitoring in Ventilated Pediatric Patients]] | |||
* [[media:Hip_infant.pdf|Hip Exam and Surveillance in Infants]]; [[Pediatric Hip Exam and Surveillance Protocol|supplement]] | * [[media:Hip_infant.pdf|Hip Exam and Surveillance in Infants]]; [[Pediatric Hip Exam and Surveillance Protocol|supplement]] | ||
* [[media:Induced_sputum_peds.pdf|Induced Sputum Collection]]; [[Pediatric Induced Sputum Collection|supplement]] | * [[media:Induced_sputum_peds.pdf|Induced Sputum Collection]]; [[Pediatric Induced Sputum Collection|supplement]] | ||
Revision as of 06:54, 4 December 2022
If you are having difficulty finding a specific guideline, Please use Ctrl+F. "Control+F" (or "Command+F" on a Mac) is the keyboard shortcut for the Find command. If you are in a document or in a web browser, pressing the Ctrl key + the F key will bring up a search box in the top right corner of the screen.
LOCAL GUIDELINE COLLECTIONS
YKHC Clinical Guidelines Book
ANMC Clinical Guidelines
CLINICAL GUIDELINES (Arranged by system)
General
Critical Care & Emergency Medicine
- Acute Coronary Syndrome (MI); supplement
- Cerebrovascular Accident; supplement
- Death Protocol; supplement
- Head Injury/Concussion (<18 years); supplement
- High-Flow Nasal Cannula (HFNC) (Pediatric); supplement
- Intubation (Adult and Pediatric); supplement
- Medevac Activation: Village to YKHC; supplement
- Medevac Activation: YKHC to Anchorage; supplement
- Military Transport for Emergencies; supplement
- Pediatric Medevacs: Bethel to Anchorage; supplement
- Procedural Sedation & Analgesia Outside the OR; supplement
- Sepsis (Adult); supplement
- Sepsis Medications (Adult); supplement
- Sepsis (Pediatric); supplement
- Status Epilepticus Treatment (Adult)
- Status Epilepticus Treatment (Pediatric); supplement
- Pediatric Critical Care Weight-Based Guide
Abuse/Assault
- Sexual Assault (≥18 Years); supplement
- Strangulation; supplement
- Suspected Physical Abuse Procedure (Pediatric); supplement
- Suspected Sexual Abuse Procedure (Pediatric); supplement
Cardiovascular
- Acute Coronary Syndrome (MI); supplement
- Aspirin for Adults >40 without Known Cardiovascular Disease; supplement
- Congestive Heart Failure; supplement
- Hypertension; supplement
- Post-MI Management; supplement
Gastrointestinal & Endocrine
- Diabetes, Type 2; supplements
- Dyspepsia/H. pylori (Adult and Pediatric); supplement
- Iron Infusion for Chronic Iron-Deficiency Anemia (Adult and Pediatrics)
- Osteoporosis Screening and Treatment; supplement
Infectious Disease
- Amoxicillin Allergy Trials (Pediatric); supplement
- Botulism; supplement
- Bronchiectasis/Chronic Cough (<18 years); supplement
- Bronchiolitis/Wheezing (3-24 months); supplement
- Croup/Stridor (6 months - 3 years); supplement
- Fever (0-90 days); supplement
- Influenza (Adult and Pediatric); supplement
- Lymphadenitis, Acute Cervical (Pediatric); supplement
- Otitis Media, Acute (3 months - 12 years); supplement
- Peritonsillar Abscess (Adult and Pediatric); supplement
- Pharyngitis (Adult and Pediatric) (Group A Strep); supplement
- Pneumonia (Adult); supplement
- Pneumonia (> 3 months); supplement
- Procalcitonin in Lower Respiratory Tract Infections (Adult); supplement
- Rabies; supplement
- Sepsis (Adult); supplement
- Sepsis Medications (Adult); supplement
- Sepsis/Septic Shock (Pediatric); supplement
- Sexually Transmitted Infections; supplement
- Sinusitis (>4 years); supplement
- Skin and Soft Tissue Infection (Adult and Pediatric); supplement
- Tuberculosis, Active Pulmonary (≥14 years); supplement
- Tuberculosis, Latent (≥14 years); supplement
- Tuberculosis Evaluation and Treatment (<14 years); supplement
- UTI (Adult); supplement
- UTI (3 months - 5 years); supplement
- Varicella (Chicken Pox), Suspected; supplement
Neonatal/Pediatric Growth & Development
- Failure to Thrive in Children <24 Months
- Late Preterm Newborns, Care of; supplement
- Newborn Early Onset Sepsis/GBS; supplement
- Neonatal Glucose Screening; supplement
- Jaundice in a Baby <4 Weeks; supplement
- Neonatal Resuscitation Summary
Neurology
- Cerebrovascular Accident; supplement
- Head Injury/Concussion (<18 years); supplement
- Seizure Evaluation (Pediatric); supplement
- Status Epilepticus Treatment (Pediatric); supplement
- Status Epilepticus Treatment (Adult)
Obstetrics
- Anemia in Pregnancy; supplement
- Diabetes,Gestational; supplement
- Ectopic Pregnancy Treatment; supplement
- First Trimester Vaginal Bleeding; supplement
- Group B Streptococcus (GBS) Maternal; supplement
- HIV Screening and Prenatal Care; supplement
- Hypertension in Pregnancy, Chronic; supplement
- Hypertension, Gestational; supplement
- Hypertension in Pregnant and Postpartum Patients, Severe; supplement
- Induction of Labor; supplement
- Intrahepatic Cholestasis of Pregnancy (IHCP); supplement
- Intrauterine Growth Restriction (IUGR); supplement
- Labor Patient in a Village; supplement
- Molar Pregnancy; supplement
- Oligohydramnios; supplement
- Post Dates Pregnancy; supplement
- Prenatal Care; supplement
- Preterm Labor (Screening, Prevention, Evaluation, and Treatment); supplement
- Preterm Premature Rupture of Membranes (PPROM); supplement
- Rhogam; supplement
- Vaginal Birth After Cesarian (VBAC); supplement
Preventative Health
- Amoxicillin Allergy Trials (Pediatric); supplement
- Aspirin for Adults >40 without Known Cardiovascular Disease; supplement
- Breast Cancer Screening; supplement
- Lead Evaluation (Pediatric); supplement
- Primary Care for Ex-Premies - Checklist
- Sports Clearance for Pediatric Patients with History of COVID-19 (return to play after COVID); supplement
- Osteoporosis Screening and Treatment; supplement
Psychiatry
- Alcohol Hangover/Withdrawal; supplement
- Attention Deficit Hyperactivity Disorder (Pediatrics); supplement
- Intoxicated Patient; supplement
- Involuntary Psychiatric Admissions (Title 47); supplement
Trauma/Injury/Ingestion
- Acetaminophen Overdose (Adult and Pediatric); supplement
- Burns (Adult and Pediatric); supplement
- Frostbite (Adult and Pediatric); supplement
- Head Injury/Concussion (<18 years); supplement
- Rabies; supplement
- Strangulation; supplement
COVID Guidelines
- Multisystem Inflammatory Syndrome (MIS C)
- Molnupiravir, Emergency Use
- Paxlovid, Emergency Use
- Sports Clearance for Pediatric Patients with History of COVID-19 (return to play after COVID); supplement
- Tixagevimab & Cilgavimab, Emergency Use
PROTOCOLS, REFERENCES, & RESOURCES (arranged by department)
Neonatal References
- Neopuff Set-Up Guide
- Pneumothorax Evacuation Protocol (coming soon)
- Surfactant (Curosurf) Administration Protocol; supplement
- Village Deliveries; supplement
Outpatient Protocols/References
- Chronic Pain; supplement
- Colon Cancer Screening; supplement
- Contraception - Quick Start; supplement
- Pre-Anesthesia Testing; supplement
Pediatric Protocols/References
- Caffeine Protocol, Post-NICU Discharge
- Care Conference Checklist
- Dexamethasone in Meningitis
- Diabetic Ketoacidosis Management (see Endocrine Pages)
- Endocrine Emergencies (see Endocrine Pages); supplement
- Endocrine Referrals/Labs and Follow-up Recommendations (see Endocrine Pages)
- ET CO2 Monitoring in Ventilated Pediatric Patients
- Hip Exam and Surveillance in Infants; supplement
- Induced Sputum Collection; supplement
- mPEWS Protocol for Pediatric Patients
- Nutritional Supplements, Documentation Requirements
- Orthotics, Documentation Requirements
- Suspected Septic Arthritis and Osteomyelitis
This category currently contains no pages or media.
